You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
雙鷺藥業(002038.SZ):獲得依帕司他片藥品註冊證書
格隆匯 06-28 19:44

格隆匯6月28日丨雙鷺藥業(002038.SZ)公佈,公司於近日收到國家藥品監督管理局核准簽發的依帕司他片(商品名:依點®)(50mg)《藥品註冊證書》。

公司於2023年2月9日向國家藥品審評中心遞交上市申請並獲得受理。依帕司他片主要用於治療糖尿病性神經病變。依帕司他是一種可逆性的醛糖還原酶非競爭性抑制劑,對醛糖還原酶具有選擇性抑制作用,通過抑制神經內山梨醇的積蓄,達到改善糖尿病末梢神經障礙的併發自覺症狀和神經功能異常的功效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account